Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: This study aims to analyze the clinical utility of electrical source imaging (ESI) of ictal rhythms in epilepsy surgery.

Methods: Medical records of 42 patients who underwent resective epilepsy surgery at Asan Medical Center (2000-2021) were reviewed. All patients underwent long-term video-EEG monitoring. EEG data were analyzed for ictal onset, rhythm patterns, and dominant frequency. Ictal ESI (IC-ESI) findings were compared with 18-fluorodeoxyglucose positron emission tomography (18-FDG-PET), ictal single-photon emission computed tomography (SPECT), and intracranial EEG to assess concordance, with surgical outcomes in Engel classification.

Results: Among 223 analyzed seizures, the overall localization accuracy of IC-ESI was 48.0 % (95 % CI: 41.5-54.5 %). Localization to the deep temporal region showed significantly higher accuracy (64.7 %, 95 % CI: 54.1-74.0 %) and sensitivity (86.4 %, 95 % CI: 75.5-93.0 %) than those outside this region (accuracy: 35.2 %, 95 % CI: 27.4-43.9 %; sensitivity: 17.4 %, 95 % CI: 11.0-26.7 %; p < 0.001 for both). At the patient level, IC-ESI demonstrated a 59.5 % accuracy (95 % CI: 44.5-73.0 %) and 76.7 % sensitivity (95 % CI: 59.1-88.2 %). Accuracy differences between IC-ESI and 18-FDG-PET and ictal SPECT were not significant (p = 0.15). Dye injection within 15.5 s of ictal EEG onset was associated with concordant SPECT and IC-ESI findings (p = 0.03). IC-ESI accuracy was independent of MRI (p = 0.60) or intracranial EEG findings (p = 0.18; 95 % CI: 0.02-1.94).

Conclusion: IC-ESI achieves accuracy comparable to that of ictal SPECT and 18-FDG-PET, supporting its reliability for identifying epileptogenic zones, particularly in temporal lobe epilepsy. Despite challenges in detecting ictal rhythms, IC-ESI adds clinical value to presurgical evaluations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.seizure.2025.05.010DOI Listing

Publication Analysis

Top Keywords

ictal
9
electrical source
8
source imaging
8
ictal rhythms
8
patients underwent
8
ic-esi
8
ic-esi findings
8
18-fdg-pet ictal
8
intracranial eeg
8
ictal spect
8

Similar Publications

This case study reports the first documented use of stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation (RFTC) to treat refractory status epilepticus (RSE). A 33-year-old woman with drug-resistant epilepsy and recurrent RSE underwent SEEG to define her epileptogenic zone. A new RSE started shortly before and continued during the SEEG exploration, being unresponsive to multiple antiseizure medications, vagal nerve stimulation, and corticosteroid therapy.

View Article and Find Full Text PDF

Slapping automatism in epileptic seizures: a case series.

Front Hum Neurosci

August 2025

Department of Neurosurgery, Affiliated Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

Background: Slapping automatism is a type of automatism observed during epileptic seizures, but its underlying electrophysiological mechanisms remain poorly understood. Stereo-electroencephalography (SEEG) provides a unique opportunity to investigate the associated cortical areas with epileptiform discharges during the slapping automatism.

Case Report: We report five cases of drug-resistant epilepsy in which SEEG recordings captured slapping automatism.

View Article and Find Full Text PDF

New implantable and wearable devices hold great promise to help patients manage their seizure disorders. One proposed application is measuring the rate of interictal epileptiform discharges as a biomarker of medication levels and seizure risk. This study aims to determine whether interictal epileptiform spike rates (spikes) are independently associated with anti-seizure medication (ASM) levels and evaluate whether spike rates are a reliable biomarker for ASM levels.

View Article and Find Full Text PDF

Objectives: Responsive neurostimulation (RNS) electrocorticographic (ECoG) data may have a role in objectively assessing the efficacy of add-on antiseizure medications (ASMs). This retrospective, multicenter, observational, 24-week study is the first to report the effects of cenobamate on RNS-detected events (RDE).

Methods: Patients included adults (≥18 years) with a history of recurrent focal seizures and implanted RNS who initiated adjunctive cenobamate ≥ 3 months after RNS implant between 4/1/20-12/15/23 and who received ≥ 2 weeks of cenobamate (≥50 mg/day).

View Article and Find Full Text PDF